New trends in substance abuse: the era of designer drugs

被引:0
|
作者
Lim-Cow, YSC [1 ]
机构
[1] Univ Catholique Louvain, Clin Univ St Luc, Psychopathol Serv, Crisis Unit, B-1200 Brussels, Belgium
来源
关键词
designer drugs; ecstasy; MDMA;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
MDMA, 3,4-methylenedioxy-methamphetamine, better known in Belgium under the name "ecstasy" is a psychoactive drug which is extremely popular among teenagers and young adults. Wrongly considered to be a safe drug, it is in fact harmful both on organic and psychological grounds. Ecstasy is known under different names in Europe: XTC, Adam, or "E'. Ecstasy addicts compel us to requestion our profiles concerning drug addicts, namely as belonging to a poor socioeconomic class or being involved in delinquency Single drug addiction is becoming extremely rare. It is rapidly giving way to the concept of multiple drug addiction. Ecstasy is frequently mixed with other substances such as antidepressants, amphetamines or strychnine. In Belgium, it is the second most consumed drug (after cannabis) at "rave" parties. This phenomenon leads to the creation of a new subculture.
引用
收藏
页码:383 / 391
页数:9
相关论文
共 50 条
  • [1] SUBSTANCE-ABUSE - THE DESIGNER DRUGS
    BEEBE, DK
    WALLEY, E
    AMERICAN FAMILY PHYSICIAN, 1991, 43 (05) : 1689 - 1698
  • [2] The Surveillance and Detection of Designer Drugs: A New Challenge in Substance Abuse and Forensic Sciences
    Thomas, B. F.
    Stout, P. R.
    Ropero-Miller, J. D.
    Cox, A. O.
    Daw, R. C.
    Pande, P. G.
    Davis, K. H.
    Grabenauer, M. E.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2012, 7 : S25 - S25
  • [3] DESIGNER DRUGS - THE CHALLENGE OF THE NEW SYNTHETIC DRUGS OF ABUSE
    HENDERSON, GL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1986, 192 : 12 - CHAL
  • [4] Designer steroids: new drugs of abuse in sport
    Catlin, D. H. C.
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2005, 28 : 24 - 24
  • [5] The evolving high: New designer drugs of abuse
    Pourmand, A.
    Armstrong, P.
    Mazer-Amirshahi, M.
    Shokoohi, H.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2014, 33 (10) : 993 - 999
  • [6] Piperazine designer drugs of abuse
    Staack, Roland F.
    LANCET, 2007, 369 (9571): : 1411 - 1413
  • [7] Metabolism of designer drugs of abuse
    Staack, RF
    Maurer, HH
    CURRENT DRUG METABOLISM, 2005, 6 (03) : 259 - 274
  • [8] Detection of new designer drugs of abuse in clinical toxicology by HPLC
    Lakatos, A.
    Lajtai, A.
    Porpaczy, Z.
    Mayer, M.
    Kovacs, G. L.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 483 - 483
  • [9] Recent Trends in Designer Drug Abuse
    Crews, Bridgit O.
    Petrie, Matthew S.
    CLINICAL CHEMISTRY, 2015, 61 (07) : 1000 - 1001
  • [10] A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs
    de Boer, D
    Bosman, I
    PHARMACY WORLD & SCIENCE, 2004, 26 (02): : 110 - 113